Asset Management One’s Genomic Health, Inc. GHDX Stock Holding History

Asset Management One’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,966	Closed	-$405K	–	1067
2019 Q3	$405K	Sell	5,966 -6,700	-53%	-$460K	﹤0.01%	955
2019 Q2	$737K	Hold	12,666	–	–	﹤0.01%	927
2019 Q1	$887K	Hold	12,666	–	–	﹤0.01%	889
2018 Q4	$807K	Hold	12,666	–	–	﹤0.01%	895
2018 Q3	$879K	Buy	+12,666	New	+$741K	﹤0.01%	918
2016 Q4	–	Sell	-35,064	Closed	-$1.01M	–	1318
2016 Q3	$1.01M	Hold	35,064	–	–	0.02%	849
2016 Q2	$908K	Hold	35,064	–	–	0.01%	877
2016 Q1	$869K	Buy	35,064 +26,134	+293%	+$717K	0.01%	908
2015 Q4	$314K	Buy	+8,930	New	+$239K	﹤0.01%	1155

Asset Management One's GHDX Position: Q4 2019 in Review

Asset Management One sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 5,966 shares — an estimated $405K sold.

Asset Management One first reported a position in GHDX in Q4 2015 and held it in 9 quarters. The position peaked at $1.01M in Q3 2016. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Asset Management One reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Asset Management One sold 5,966 Genomic Health, Inc. shares in Q4 2019, an estimated $405K.
Asset Management One first reported a position in Genomic Health, Inc. in Q4 2015 and held it in 9 quarters.
Asset Management One's Genomic Health, Inc. position peaked at $1.01M in Q3 2016.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Asset Management One's 13F filing for Q4 2019, filed 14 Feb 2020.